antitrust

A federal jury found that Medtronic, which plans to appeal the ruling, unlawfully monopolized the bipolar surgical device market through anticompetitive bundling and exclusive-deal practices that harmed rival Applied Medical.

The regulator imposed a series of requirements for the tech companies that must be followed for at least 10 years.

The regulator said it was not satisfied with Google's offer to silo Fitbit-collected data so that it could not be used for advertising purposes.

Also: Khosla heir calls digital health investment a big disappointment; Humana and Philips partner on MA member monitoring.